Icon

PROGLYCEM (nda017425)- (50MG,100MG)

DIAZOXIDE TEVA BRANDED PHARM
50MG,100MG
No No
Expired Expired
None None
None No
PROGLYCEM® (ORAL DIAZOXIDE) is useful in the management of hypoglycemia due to hyperinsulinism associated with the following conditions: Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy. Infants and Children: Leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, or adenomatosis. PROGLYCEM® may be used preoperatively as a temporary measure, and postoperatively, if hypoglycemia persists.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG ** ** - - -
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.